- Home
- POAI vs AIMD Comparison
POAI vs AIMD Comparison
Compare POAI & AIMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- POAI
- AIMD
- Stock Information
- Founded
- POAI 2002
- AIMD 1984
- Country
- POAI United States
- AIMD United States
- Employees
- POAI N/A
- AIMD N/A
- Industry
- POAI Industrial Specialties
- AIMD Biotechnology: Pharmaceutical Preparations
- Sector
- POAI Health Care
- AIMD Health Care
- Exchange
- POAI Nasdaq
- AIMD Nasdaq
- Market Cap
- POAI 8.9M
- AIMD 11.9M
- IPO Year
- POAI N/A
- AIMD N/A
- Fundamental
- Price
- POAI $0.79
- AIMD $2.94
- Analyst Decision
- POAI Hold
- AIMD
- Analyst Count
- POAI 1
- AIMD 0
- Target Price
- POAI N/A
- AIMD N/A
- AVG Volume (30 Days)
- POAI 158.5K
- AIMD 72.7K
- Earning Date
- POAI 08-12-2025
- AIMD 08-04-2025
- Dividend Yield
- POAI N/A
- AIMD N/A
- EPS Growth
- POAI N/A
- AIMD N/A
- EPS
- POAI N/A
- AIMD N/A
- Revenue
- POAI $1,729,269.00
- AIMD $106,207.00
- Revenue This Year
- POAI $486.27
- AIMD N/A
- Revenue Next Year
- POAI $65.50
- AIMD N/A
- P/E Ratio
- POAI N/A
- AIMD N/A
- Revenue Growth
- POAI 24.17
- AIMD 13.38
- 52 Week Low
- POAI $0.55
- AIMD $2.00
- 52 Week High
- POAI $3.06
- AIMD $5.00
- Technical
- Relative Strength Index (RSI)
- POAI 33.09
- AIMD 50.61
- Support Level
- POAI $0.73
- AIMD $3.07
- Resistance Level
- POAI $0.86
- AIMD $3.34
- Average True Range (ATR)
- POAI 0.05
- AIMD 0.24
- MACD
- POAI -0.00
- AIMD 0.04
- Stochastic Oscillator
- POAI 38.43
- AIMD 60.37
About POAI Predictive Oncology Inc.
Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment.
About AIMD Ainos Inc.
Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, and telehealth-friendly POCTs powered by the AI Nose technology platform.